Persistence of Nevirapine in Breast Milk after Discontinuation of Treatment
Open Access
- 1 August 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (3) , 391-394
- https://doi.org/10.1086/519427
Abstract
The objective of this study was to serially quantitate the concentration of nevirapine in breast milk after discontinuation of treatment. Samples were collected from both breasts of a human immunodeficiency virus–infected patient for 3 weeks. Nevirapine was quantifiable for up to 17 days after discontinuation of therapy; total nevirapine concentrations remained above the 90% inhibitory concentration for 6 days, and no differences were observed between breasts.Keywords
This publication has 15 references indexed in Scilit:
- Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newbornsAIDS, 2005
- Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose NevirapineThe Journal of Infectious Diseases, 2005
- Antiretroviral Concentrations in Breast‐Feeding Infants of Women in Botswana Receiving Antiretroviral TreatmentThe Journal of Infectious Diseases, 2005
- Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individualsClinical Pharmacology & Therapeutics, 2005
- Comparison of Nevirapine (NVP) Resistance in Ugandan Women 7 Days vs. 6–8 Weeks after Single-Dose NVP Prophylaxis: HIVNET 012AIDS Research and Human Retroviruses, 2004
- Clinical implications of stopping nevirapine‐based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistanceHIV Medicine, 2004
- Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2004
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their NeonatesThe Journal of Infectious Diseases, 1998
- Drugs in Human MilkClinical Pharmacokinetics, 1988